These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
255 related articles for article (PubMed ID: 23470966)
1. Inhibition of established micrometastases by targeted drug delivery via cell surface-associated GRP78. Miao YR; Eckhardt BL; Cao Y; Pasqualini R; Argani P; Arap W; Ramsay RG; Anderson RL Clin Cancer Res; 2013 Apr; 19(8):2107-16. PubMed ID: 23470966 [TBL] [Abstract][Full Text] [Related]
2. Proapoptotic Cyclic Peptide BC71 Targets Cell-Surface GRP78 and Functions as an Anticancer Therapeutic in Mice. Kao C; Chandna R; Ghode A; Dsouza C; Chen M; Larsson A; Lim SH; Wang M; Cao Z; Zhu Y; Anand GS; Ge R EBioMedicine; 2018 Jul; 33():22-32. PubMed ID: 29907328 [TBL] [Abstract][Full Text] [Related]
3. Autoantibodies against the cell surface-associated chaperone GRP78 stimulate tumor growth via tissue factor. Al-Hashimi AA; Lebeau P; Majeed F; Polena E; Lhotak Š; Collins CAF; Pinthus JH; Gonzalez-Gronow M; Hoogenes J; Pizzo SV; Crowther M; Kapoor A; Rak J; Gyulay G; D'Angelo S; Marchiò S; Pasqualini R; Arap W; Shayegan B; Austin RC J Biol Chem; 2017 Dec; 292(51):21180-21192. PubMed ID: 29066620 [TBL] [Abstract][Full Text] [Related]
4. Betulinic acid chemosensitizes breast cancer by triggering ER stress-mediated apoptosis by directly targeting GRP78. Cai Y; Zheng Y; Gu J; Wang S; Wang N; Yang B; Zhang F; Wang D; Fu W; Wang Z Cell Death Dis; 2018 May; 9(6):636. PubMed ID: 29802332 [TBL] [Abstract][Full Text] [Related]
5. Inhibition of breast cancer growth and metastasis by a biomimetic peptide. Lee E; Lee SJ; Koskimaki JE; Han Z; Pandey NB; Popel AS Sci Rep; 2014 Nov; 4():7139. PubMed ID: 25409905 [TBL] [Abstract][Full Text] [Related]
6. Cell surface expression of the stress response chaperone GRP78 enables tumor targeting by circulating ligands. Arap MA; Lahdenranta J; Mintz PJ; Hajitou A; Sarkis AS; Arap W; Pasqualini R Cancer Cell; 2004 Sep; 6(3):275-84. PubMed ID: 15380518 [TBL] [Abstract][Full Text] [Related]
7. A nanotherapeutic approach to selectively eliminate metastatic breast cancer cells by targeting cell surface GRP78. Shin J; Kim B; Lager TW; Mejia F; Guldner I; Conner C; Zhang S; Panopoulos AD; Bilgicer B Nanoscale; 2023 Aug; 15(32):13322-13334. PubMed ID: 37526009 [TBL] [Abstract][Full Text] [Related]
8. Quantum dot-conjugated anti-GRP78 scFv inhibits cancer growth in mice. Xu W; Liu L; Brown NJ; Christian S; Hornby D Molecules; 2012 Jan; 17(1):796-808. PubMed ID: 22249409 [TBL] [Abstract][Full Text] [Related]
9. Isthmin targets cell-surface GRP78 and triggers apoptosis via induction of mitochondrial dysfunction. Chen M; Zhang Y; Yu VC; Chong YS; Yoshioka T; Ge R Cell Death Differ; 2014 May; 21(5):797-810. PubMed ID: 24464222 [TBL] [Abstract][Full Text] [Related]
10. A peptidic unconjugated GRP78/BiP ligand modulates the unfolded protein response and induces prostate cancer cell death. Maddalo D; Neeb A; Jehle K; Schmitz K; Muhle-Goll C; Shatkina L; Walther TV; Bruchmann A; Gopal SM; Wenzel W; Ulrich AS; Cato AC PLoS One; 2012; 7(10):e45690. PubMed ID: 23049684 [TBL] [Abstract][Full Text] [Related]
11. Cell Surface GRP78 Accelerated Breast Cancer Cell Proliferation and Migration by Activating STAT3. Yao X; Liu H; Zhang X; Zhang L; Li X; Wang C; Sun S PLoS One; 2015; 10(5):e0125634. PubMed ID: 25973748 [TBL] [Abstract][Full Text] [Related]
12. The COOH-Terminal Proline-Rich Region of GRP78 Is a Key Regulator of Its Cell Surface Expression and Viability of Tamoxifen-Resistant Breast Cancer Cells. Tseng CC; Zhang P; Lee AS Neoplasia; 2019 Aug; 21(8):837-848. PubMed ID: 31306849 [TBL] [Abstract][Full Text] [Related]
13. Endoplasmic Reticulum Stress Protein GRP78 Modulates Lipid Metabolism to Control Drug Sensitivity and Antitumor Immunity in Breast Cancer. Cook KL; Soto-Pantoja DR; Clarke PA; Cruz MI; Zwart A; Wärri A; Hilakivi-Clarke L; Roberts DD; Clarke R Cancer Res; 2016 Oct; 76(19):5657-5670. PubMed ID: 27698188 [TBL] [Abstract][Full Text] [Related]
14. Peptidomimetic Src/pretubulin inhibitor KX-01 alone and in combination with paclitaxel suppresses growth, metastasis in human ER/PR/HER2-negative tumor xenografts. Anbalagan M; Ali A; Jones RK; Marsden CG; Sheng M; Carrier L; Bu Y; Hangauer D; Rowan BG Mol Cancer Ther; 2012 Sep; 11(9):1936-47. PubMed ID: 22784709 [TBL] [Abstract][Full Text] [Related]
15. Betulinic Acid Suppresses Breast Cancer Metastasis by Targeting GRP78-Mediated Glycolysis and ER Stress Apoptotic Pathway. Zheng Y; Liu P; Wang N; Wang S; Yang B; Li M; Chen J; Situ H; Xie M; Lin Y; Wang Z Oxid Med Cell Longev; 2019; 2019():8781690. PubMed ID: 31531187 [TBL] [Abstract][Full Text] [Related]
16. GRP78 regulates CD44v membrane homeostasis and cell spreading in tamoxifen-resistant breast cancer. Tseng CC; Stanciauskas R; Zhang P; Woo D; Wu K; Kelly K; Gill PS; Yu M; Pinaud F; Lee AS Life Sci Alliance; 2019 Aug; 2(4):. PubMed ID: 31416894 [TBL] [Abstract][Full Text] [Related]
17. Critical role of the stress chaperone GRP78/BiP in tumor proliferation, survival, and tumor angiogenesis in transgene-induced mammary tumor development. Dong D; Ni M; Li J; Xiong S; Ye W; Virrey JJ; Mao C; Ye R; Wang M; Pen L; Dubeau L; Groshen S; Hofman FM; Lee AS Cancer Res; 2008 Jan; 68(2):498-505. PubMed ID: 18199545 [TBL] [Abstract][Full Text] [Related]
18. Development and characterization of a preclinical model of breast cancer lung micrometastatic to macrometastatic progression. Bailey-Downs LC; Thorpe JE; Disch BC; Bastian A; Hauser PJ; Farasyn T; Berry WL; Hurst RE; Ihnat MA PLoS One; 2014; 9(5):e98624. PubMed ID: 24878664 [TBL] [Abstract][Full Text] [Related]
19. Pharmacological induction of cell surface GRP78 contributes to apoptosis in triple negative breast cancer cells. Raiter A; Yerushalmi R; Hardy B Oncotarget; 2014 Nov; 5(22):11452-63. PubMed ID: 25360516 [TBL] [Abstract][Full Text] [Related]
20. GRP78/BiP inhibits endoplasmic reticulum BIK and protects human breast cancer cells against estrogen starvation-induced apoptosis. Fu Y; Li J; Lee AS Cancer Res; 2007 Apr; 67(8):3734-40. PubMed ID: 17440086 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]